treatment

treatment

  • Activist: SA’s Ebola Role is Unsatisfactory

    Director of the University of Pretoria's Centre for Human Rights, Frans Viljoen, believes South Africa should have played the leading role in the fight against the spread of the Ebola virus in Africa.

    Speaking at the University of Pretoria’s panel discussion on South Africa's preparedness for Ebola, Viljoen stresses that, “As a beacon of public health on the continent, as a country that stands for African problems being resolved by Africans themselves, South Africa should have taken a leading role.”

    He states that the country should have taken more proactive steps, instead of merely making sure there was protective clothing available.

    To read the article titled, “SA negating Ebola role: expert,” click here.

    Source: 
    IOL News
  • World Losing Battle Against Ebola

    The international medical agency, Medecins sans Frontieres, says the world was ‘losing the battle’ to contain Ebola as the United Nations (UN) warned of severe food shortages in the hardest-hit countries.

    MSF told a UN briefing in New York that world leaders were failing to address the epidemic and called for an urgent global biological disaster response to get aid and personnel to West Africa.

    MSF international president, Joanne Liu, points out that, "Six months into the worst Ebola epidemic in history, the world is losing the battle to contain it. Leaders are failing to come to grips with this transnational threat."

    To read the article titled, “World 'losing battle' to contain Ebola: MSF,” click here.

    Source: 
    Sowetan Live
  • Malawi Puts HIV-Positive Women on ARVs

    Malawi President, Peter Mutharika, says his country was the first to adopt a policy of putting all HIV positive pregnant and breast feeding women on anti-retroviral (ARV) drugs regardless of their CD4 Count.

    Speaking at the signing of the Protect the Goal Campaign as a sign of commitment to the fight against HIV and AIDS, Mutharika argues that the policy has significantly reduced the number of children born with HIV and has taken Malawi closer to achieving an HIV free generation.

    “Malawi has come a long way in the fight against HIV and AIDS. As a country, we have continued to scale up interventions that work. Already more than seven million people, almost half of the population of this country have been tested for HIV and have received their results,” he adds.

    To read the article titled, “Malawi first country to put HIV positive pregnant women on ARVs - APM,” click here.

    Source: 
    Malawi News Agency Online
  • Botswana Ordered to Provide ARVs to Prisoners

    Botswana's High Court orders the government to provide treatment to HIV-positive foreign prisoners at the state's expense.

    Justice Bengbame Sechele, ruled that the denial of anti-retroviral (ARV) treatment to foreign inmates violated their rights.

    The Botswana Network on Ethics, Law and HIV/AIDS supports the challenge against government policy, saying it violated the prisoners' constitutional right to equality, dignity and non-discrimination.

    To read the article titled, “Botswana has to pay HIV treatment for foreigners,” click here.

    Source: 
    News 24
  • Ebola Patients Offered Experimental Drugs

    The World Health Organisation (WHO) says people infected in the West African Ebola outbreak can be offered untested drugs, however, the scarcity of supplies has raised questions about who gets priority access to treatment.

    Liberia plans to treat two infected doctors with an unproven Ebola medicine called ZMapp, as they become the first Africans to receive the drug, which has already been given to a Spanish priest who later died and two United States aid workers.

    The outbreak is the world's largest and deadliest and the United Nations’ World Health Organisation has already declared it an international health emergency.

    To read an article titled, “WHO backs use of experimental drugs,” click here.

    Source: 
    IOL News
  • New TB Drug Gets Mixed Reaction

    The University of Cape Town's (UCT) head of Pulmonology division, Professor Keertan Dheda, says he is less optimistic about the cocktail of new drug resistance tuberculosis (TB).

    The PaMZ three-drug combo from the Global Alliance for TB Drug Development is said to cure the disease more quickly than current regimens.

    The PaMZ regimen shows promise to be effective in all (100 percent) of drug-sensitive patients and about 30 percent of patients with MDR-TB

    To read the article titled, "New TB treatment drug gets mixed reaction," click here.

    Source: 
    SABC News
  • HIV Infection Rate in Children Declines

    According to a study conducted by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, looking into the global burden of disease with a particular focus on HIV, tuberculosis (TB) and malaria, new HIV infections in South African children under five years old have dropped by more than three quarters between 2003 and 2013, from 56 000 to 7 600.

    The authors of the study argue that the decrease in HIV infections and AIDS-related deaths in this age group is likely a result of the country’s ‘expanded access to child-focused intervention’ such as the prevention of mother-to-child transmission programmes. 

    Christopher Murray, IHME director and an author of the study believes the global investment in HIV treatment is saving lives rapidly, but notes that the quality of antiretroviral programmes varies widely and in order to reduce HIV-related deaths even further, the country needs to learn from the best programmes and do away with the worst ones.

    To read the article titled, “HIV infections in children under five down by over three quarters,” click here.

    Source: 
    Mail and Guardian
  • Call to Provide AIDS Treatment

    Countries have to test for HIV at least 90 percent of their populations and make sure that 90 percent of HIV positive people are on treatment.

    This is one of the bold and ambitious targets set by the Joint United Nations Programme on HIV/AIDS (UNAIDS) at the 20th International Aids Conference in Melbourne, Australia.

    After about three decades of the HIV/AIDS pandemic, the United Nations has now called on countries to end the scourge of this disease.

    To read the article titled, “UNAIDS pushes for an end to Aids epidemic,” click here.

    Source: 
    SABC News
  • Desmond Tutu HIV Foundation: Senior Finance and Project Administrator

    Desmond Tutu HIV Foundation
    Please note: this opportunity closing date has passed and may not be available any more.
    Opportunity closing date: 
    Monday, June 23, 2014
    Opportunity type: 
    Employment
    The Desmond Tutu HIV Foundation’s mission is the pursuit of excellence in research, treatment, training and prevention of HIV and related infections.

    The Desmond Tutu HIV Foundation seeks to appoint a Senior Financial and Project Administrator, based in Masipumelele office, Cape Town.

    This is a full-time two year fixed term contract position.

    Responsibilities:
    • Financial Administration:
      • Acquire comprehensive knowledge of the donor’s financial requirements;
      • Ensure that all financial requirements are adhered to;
      • Ensure compliance to budget requirements;
      • Monthly bank reconciliations;
      • Manage and reconcile petty cash;
      • Draft monthly income and expense reports;
      • Journal entries;
      • Prepare bank transfers;
      • Assist with preparation for annual project audit ;
    • Project Administration:
      • Project procurement;
      • Sourcing quotes and vendors where applicable;
      • Assist with event planning: Booking of venues, catering;
      • Travel arrangement.for project staff;
      • Basic office equipment and building maintenance.
    Requirements:
    • Minimum of four to five years’ work experience in a NGO environment;
    • Three year accounting / finance related diploma or certificate;
    • Fully computer literate including advanced excel skills;
    • Experience in SAP/ related accounting package would be an advantage;
    • Valid driver’s licence;
    • Good communicator - written and oral;
    • NIH/USAID experience.
    Salary range: R11 500.00 - R18 000.00 (no benefits offered).

    To apply, submit a CV and motivational letter, quoting the name of the position you are applying for and a CV which includes the names and contact details of at least two professional references to: The Human Resource Manager via email: jobs@hiv-research.org.za or fax to 021 650 6963.

    Please quote the source of this advertisement in your application - NGO Pulse Portal.

    Only short-listed candidates will be contacted. The Desmond Tutu HIV Foundation is committed to equity in our employment practices. It is the organisation's intention to appoint individuals with the aim of meeting our equity objectives.

    The Desmond Tutu HIV Foundation reserves the right not to appoint if no suitable candidate is identified.
     
    If you are a foreign national applying for this position please attach a copy of your work permit to your application.
     
    If you have not heard from us within two weeks after the closing date please consider you application as unsuccessful.
     
    Desmond Tutu HIV Foundation is a child friendly organisation committed to the protection of children.
     
    For more about the Desmond Tutu HIV Foundation, refer to www.desmondtutuhivfoundation.org.za.

    For other vacancies in the NGO sector, refer to www.ngopulse.org/vacancies.

    ------------------------------------------------------------------------

    Want to reach the widest spectrum of NGO and development stakeholders in South Africa as part of your communication and outreach objectives? Learn more about how the NGO Pulse Premium Advertising Service can support your communication requirements. Visit http://goo.gl/MUCvL for more information.
     
  • Lack of Information Hampers Malaria Fight

    According to a new study, some 60 percent of countries where malaria is endemic lack solid information about the quality of available drugs to treat the deadly disease.
     
    The study, published in the Malaria Journal in April, looked at 251 reports from 104-malaria endemic countries since 1946, and found that of the 43 countries that had some information about anti-malarial quality, more than half of these - 25 -  had only one or two published reports available.
     
    "Estimates of anti-malarial quality vary widely depending on the sampling methodology used, with most reports not employing rigorous scientific techniques, potentially biasing results," says the reports.
     
    To read the article titled, “Unknown unknowns hamper global malaria fight,” click here.

    Source: 
    All Africa
Syndicate content